uniQure N.V. (QURE) was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company since Nov 28, as the stock is now down over 6%.
Over the last 30 days, the company witnessed two positive and one negative estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
uniQure N.V. currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked biomedical stocks include Affymetrix Inc. (AFFX), ANI Pharmaceuticals, Inc. (ANIP) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment